Proofreading exonuclease activity of replicative polymerase epsilon promotes cellular tolerance to arabinosides in CTF18-dependent and -independent manner

Abstract

Ara-A, Ara-C, Ara-G, and Ara-T are arabinose sugars combined with adenine, cytosine, guanine, and thymine bases, respectively. These drugs are clinically important as these drugs are commonly used as anti-viral and anti-cancer drugs. Ara-C, an arabinoside, serves as a chain terminator of deoxyribonucleic acid (DNA) replication by interfering with replication after it is incorporated at the 3′ end of nascent DNA, thereby restricting the proliferation of viruses and cancer cells. The incorporated Ara-CMP is efficiently removed by the proofreading exonuclease activity of polymerase epsilon (Polε), in which the alternative clamp loader CTF18 plays a pivotal role. However, the requirement of CTF18 for the removal of the other arabinosides from the 3′ end of nascent DNA remains unclear. Here, we explored DNA repair pathways responsible for the cellular tolerance to Ara-A and found that cells deficient in the proofreading exonuclease activity of Polε (POLE1 ^exo−/−) showed the highest sensitivity to Ara-A. This activity was also required for cellular tolerance to Ara-G and Ara-T. CTF18 ^−/− cells showed higher Ara-A sensitivity than wild-type cells, though it was critically lower than that of POLE1 ^exo−/− cells. Similar trends were observed for the sensitivity to Ara-G and Ara-T. These results indicate that these arabinosides are removed by Polε proofreading exonuclease activity, and CTF18 is pivotal for Polε-mediated Ara-C removal but does not play critical roles for Polε-mediated removal of Ara-A, Ara-G, and Ara-T. In this study, we unveiled a difference between Ara-C and the other arabinosides (Ara-A, Ara-G, and Ara-T) in the removal from the 3′ end of nascent DNA.

Keywords

Polymerase epsilon / Nucleoside analog / Chain terminator / Replication / DNA repair

References

[1] Abe T, Branzei D, Hirota K. DNA Damage tolerance mechanisms revealed from the analysis of immunoglobulin V gene diversification in avian DT40 cells. Genes (Basel), 2018, 9(12): 614,

[2] Abe T, Kawasumi R, Arakawa H, Hori T, Shirahige K, Losada A, Fukagawa T, Branzei D. Chromatin determinants of the inner-centromere rely on replication factors with functions that impart cohesion. Oncotarget, 2016, 7: 67934-67947,

[3] Ahmad T, Kawasumi R, Taniguchi T, Abe T, Terada K, Tsuda M, Shimizu N, Tsurimoto T, Takeda S, Hirota K. The proofreading exonuclease of leading-strand DNA polymerase epsilon prevents replication fork collapse at broken template strands. Nucleic Acids Research, 2023, 51(22): 12288-12302,

[4] Arakawa H, Lodygin D, Buerstedde JM. Mutant loxP vectors for selectable marker recycle and conditional knock-outs. BMC Biotechnology, 2001, 1: 7,

[5] Baris Y, Taylor MRG, Aria V, Yeeles JTP. Fast and efficient DNA replication with purified human proteins. Nature, 2022, 606: 204-210,

[6] Carter CJ, Mekkawy AH, Morris DL. Role of human nucleoside transporters in pancreatic cancer and chemoresistance. World Journal of Gastroenterology, 2021, 27: 6844-6860,

[7] Cejka P, Symington LS. DNA end resection: mechanism and control. Annual Review of Genetics, 2021, 55: 285-307,

[8] Cohen SS. The mechanisms of lethal action of arabinosyl cytosine (araC) and arabinosyl adenine (araA). Cancer, 1977, 40: 509-518,

[9] Demin AA, Hirota K, Tsuda M, Adamowicz M, Hailstone R, Brazina J, Gittens W, Kalasova I, Shao Z, Zha S, et al.. XRCC1 prevents toxic PARP1 trapping during DNA base excision repair. Molecular Cell, 2021, 81: 3018-3030.e3015,

[10] Fujita M, Sasanuma H, Yamamoto KN, Harada H, Kurosawa A, Adachi N, Omura M, Hiraoka M, Takeda S, Hirota K. Interference in DNA replication can cause mitotic chromosomal breakage unassociated with double-strand breaks. PLoS ONE, 2013, 8,

[11] Geraghty RJ, Aliota MT, Bonnac LF. Broad-spectrum antiviral strategies and nucleoside analogues. Viruses, 2021, 13: 667,

[12] Hill JM, Wiggins CA, Kwon BS, Gentry GA, Gangarosa LP Sr. Thymine arabinoside (Ara-T) topical and iontophoretic application for herpes simplex virus type 1 and type 2 skin infections in hairless mice. Methods and Findings in Experimental and Clinical Pharmacology, 1984, 6: 17-20

[13] Hirota K, Ooka M, Shimizu N, Yamada K, Tsuda M, Ibrahim MA, Yamada S, Sasanuma H, Masutani M, Takeda S. XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA. Genes to Cells, 2022, 27: 331-344,

[14] Hirota K, Sonoda E, Kawamoto T, Motegi A, Masutani C, Hanaoka F, Szüts D, Iwai S, Sale JE, Lehmann A, et al.. Simultaneous disruption of two DNA polymerases, Polη and Polζ, in Avian DT40 cells unmasks the role of Polη in cellular response to various DNA lesions. PLoS Genetics, 2010, 6,

[15] Hirota K, Tsuda M, Mohiuddin, Tsurimoto T, Cohen IS, Livneh Z, Kobayashi K, Narita T, Nishihara K, Murai J, et al.. In vivo evidence for translesion synthesis by the replicative DNA polymerase δ. Nucleic Acids Research, 2016, 44: 7242-7250

[16] Hirota K, Yoshikiyo K, Guilbaud G, Tsurimoto T, Murai J, Tsuda M, Phillips LG, Narita T, Nishihara K, Kobayashi K, et al.. The POLD3 subunit of DNA polymerase δ can promote translesion synthesis independently of DNA polymerase ζ. Nucleic Acids Research, 2015, 43: 1671-1683,

[17] Holzer S, Rzechorzek NJ, Short IR, Jenkyn-Bedford M, Pellegrini L, Kilkenny ML. Structural basis for inhibition of human primase by arabinofuranosyl nucleoside analogues fludarabine and vidarabine. ACS Chemical Biology, 2019, 14: 1904-1912,

[18] Honma Y, Niitsu N. Vidarabine and 2-deoxycoformycin as antileukemic agents against monocytic leukemia. Leukaemia & Lymphoma, 2000, 39: 57-66,

[19] Ji K, Kogame T, Choi K, Wang X, Lee J, Taniguchi Y, Takeda S. A novel approach using DNA-repair-deficient chicken DT40 cell lines for screening and characterizing the genotoxicity of environmental contaminants. Environmental Health Perspectives, 2009, 117: 1737-1744,

[20] Kawasumi R, Abe T, Psakhye I, Miyata K, Hirota K, Branzei D. Vertebrate CTF18 and DDX11 essential function in cohesion is bypassed by preventing WAPL-mediated cohesin release. Genes & Development, 2021, 35: 1368-1382,

[21] Kikuchi K, Taniguchi Y, Hatanaka A, Sonoda E, Hochegger H, Adachi N, Matsuzaki Y, Koyama H, van Gent DC, Jasin M, et al.. Fen-1 facilitates homologous recombination by removing divergent sequences at DNA break ends. Molecular and Cellular Biology, 2005, 25: 6948-6955,

[22] Kline J, Larson RA. Nelarabine in the treatment of refractory T-cell malignant diseases. Expert Opinion on Pharmacotherapy, 2006, 7: 1791-1799,

[23] Kobayashi K, Guilliam TA, Tsuda M, Yamamoto J, Bailey LJ, Iwai S, Takeda S, Doherty AJ, Hirota K. Repriming by PrimPol is critical for DNA replication restart downstream of lesions and chain-terminating nucleosides. Cell Cycle, 2016, 15: 1997-2008,

[24] Kobayashi S, Kasaishi Y, Nakada S, Takagi T, Era S, Motegi A, Chiu RK, Takeda S, Hirota K. Rad18 and Rnf8 facilitate homologous recombination by two distinct mechanisms, promoting Rad51 focus formation and suppressing the toxic effect of nonhomologous end joining. Oncogene, 2015, 34: 4403-4411,

[25] Korona DA, Lecompte KG, Pursell ZF. The high fidelity and unique error signature of human DNA polymerase epsilon. Nucleic Acids Research, 2011, 39: 1763-1773,

[26] Lee TH, Kang TH. DNA oxidation and excision repair pathways. International Journal of Molecular Sciences, 2019, 20: 6092,

[27] Martin RW, Orelli BJ, Yamazoe M, Minn AJ, Takeda S, Bishop DK. RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors. Cancer Research, 2007, 67: 9658-9665,

[28] Morrison C, Sonoda E, Takao N, Shinohara A, Yamamoto K, Takeda S. The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO Journal, 2000, 19: 463-471,

[29] Mouhieddine TH, Nokkari A, Itani MM, Chamaa F, Bahmad H, Monzer A, El-Merahbi R, Daoud G, Eid A, Kobeissy FH, et al.. Metformin and Ara-a effectively suppress brain cancer by targeting cancer stem/progenitor cells. Frontiers in Neuroscience, 2015, 9: 442,

[30] Murakami T, Takano R, Takeo S, Taniguchi R, Ogawa K, Ohashi E, Tsurimoto T. Stable interaction between the human proliferating cell nuclear antigen loader complex Ctf18-replication factor C (RFC) and DNA polymerase epsilon is mediated by the cohesion-specific subunits, Ctf18, Dcc1, and Ctf8. Journal of Biological Chemistry, 2010, 285: 34608-34615,

[31] Nakazato A, Kajita K, Ooka M, Akagawa R, Abe T, Takeda S, Branzei D, Hirota K. SPARTAN promotes genetic diversification of the immunoglobulin-variable gene locus in avian DT40 cells. DNA Repair (Amst), 2018, 68: 50-57,

[32] Nick McElhinny SA, Gordenin DA, Stith CM, Burgers PM, Kunkel TA. Division of labor at the eukaryotic replication fork. Molecular Cell, 2008, 30: 137-144,

[33] Niitsu N, Yamamoto-Yamaguchi Y, Kasukabe T, Okabe-Kado J, Umeda M, Honma Y. Antileukemic efficacy of 2-deoxycoformycin in monocytic leukemia cells. Blood, 2000, 96: 1512-1516,

[34] Ogilvie KK, Slotin L, Rheault P. Novel substrate of adenosine deaminase. Biochemical and Biophysical Research Communications, 1971, 45: 297-300,

[35] Ooka M, Abe T, Cho K, Koike K, Takeda S, Hirota K. Chromatin remodeler ALC1 prevents replication-fork collapse by slowing fork progression. PLoS ONE, 2018, 13,

[36] Pandit B, Royzen M. Recent development of prodrugs of gemcitabine. Genes (Basel), 2022, 13: 466,

[37] Pommier Y, Huang SY, Gao R, Das BB, Murai J, Marchand C. Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2). DNA Repair (Amst), 2014, 19: 114-129,

[38] Quinet A, Carvajal-Maldonado D, Lemacon D, Vindigni A. DNA fiber analysis: mind the gap!. Methods in Enzymology, 2017, 591: 55-82,

[39] Rashbaum SA, Cozzarelli NR. Mechanism of DNA synthesis inhibition by arabinosyl cytosine and arabinosyl adenine. Nature, 1976, 264: 679-680,

[40] Robak T. New nucleoside analogs for patients with hematological malignancies. Expert Opinion on Investigational Drugs, 2011, 20: 343-359,

[41] Saberi A, Nakahara M, Sale JE, Kikuchi K, Arakawa H, Buerstedde JM, Yamamoto K, Takeda S, Sonoda E. The 9-1-1 DNA clamp is required for immunoglobulin gene conversion. Molecular and Cellular Biology, 2008, 28: 6113-6122,

[42] Sadowski LA, Upadhyay R, Greeley ZW, Margulies BJ. Current drugs to treat infections with herpes simplex viruses-1 and -2. Viruses, 2021, 13: 1228,

[43] Shimizu N, Ooka M, Takagi T, Takeda S, Hirota K. Distinct DNA damage spectra induced by ionizing radiation in normoxic and hypoxic cells. Radiation Research, 2015, 184: 442-448,

[44] Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet, 2018, 392: 593-606,

[45] Sinha RP, Häder DP. UV-induced DNA damage and repair: A review. Photochemical & Photobiological Sciences, 2002, 1: 225-236,

[46] Stokes K, Winczura A, Song B, Piccoli G, Grabarczyk DB. Ctf18-RFC and DNA Pol ϵ form a stable leading strand polymerase/clamp loader complex required for normal and perturbed DNA replication. Nucleic Acids Research, 2020, 48: 8128-8145,

[47] Tada K, Kobayashi M, Takiuchi Y, Iwai F, Sakamoto T, Nagata K, Shinohara M, Io K, Shirakawa K, Hishizawa M, et al.. Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia. Science Advances, 2015, 1,

[48] Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H, Yamaguchi-Iwai Y, Shinohara A, Takeda S. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO Journal, 1998, 17: 5497-5508,

[49] Takizawa Y, Qing Y, Takaku M, Ishida T, Morozumi Y, Tsujita T, Kogame T, Hirota K, Takahashi M, Shibata T, et al.. GEMIN2 promotes accumulation of RAD51 at double-strand breaks in homologous recombination. Nucleic Acids Research, 2010, 38: 5059-5074,

[50] Tsuda M, Kitamasu K, Kumagai C, Sugiyama K, Nakano T, Ide H. Tyrosyl-DNA phosphodiesterase 2 (TDP2) repairs topoisomerase 1 DNA-protein crosslinks and 3'-blocking lesions in the absence of tyrosyl-DNA phosphodiesterase 1 (TDP1). DNA Repair (Amst), 2020, 91–92,

[51] Tsuda M, Terada K, Ooka M, Kobayashi K, Sasanuma H, Fujisawa R, Tsurimoto T, Yamamoto J, Iwai S, Kadoda K, et al.. The dominant role of proofreading exonuclease activity of replicative polymerase ε in cellular tolerance to cytarabine (Ara-C). Oncotarget, 2017, 8: 33457-33474,

[52] Valente D, Gentileschi MP, Guerrisi A, Bruzzaniti V, Morrone A, Soddu S, Verdina A. Factors to consider for the correct use of γH2AX in the evaluation of DNA double-strand breaks damage caused by ionizing radiation. Cancers (Basel), 2022, 14: 6204,

[53] Wang D, Wu W, Callen E, Pavani R, Zolnerowich N, Kodali S, Zong D, Wong N, Noriega S, Nathan WJ, et al.. Active DNA demethylation promotes cell fate specification and the DNA damage response. Science, 2022, 378: 983-989,

[54] Washif M, Ahmad T, Hosen MB, Rahman MR, Taniguchi T, Okubo H, Hirota K, Kawasumi R. CTF18-RFC contributes to cellular tolerance against chain-terminating nucleoside analogs (CTNAs) in cooperation with proofreading exonuclease activity of DNA polymerase ε. DNA Repair (Amst), 2023, 127,

[55] Witkowski JT, Robins RK, Sidwell RW, Simon LN. Design, synthesis, and broad spectrum antiviral activity of 1-D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides. Journal of Medicinal Chemistry, 1972, 15: 1150-1154,

[56] Yamamoto KN, Kobayashi S, Tsuda M, Kurumizaka H, Takata M, Kono K, Jiricny J, Takeda S, Hirota K. Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway. Proceedings of the National Academy of Sciences, 2011, 108: 6492-6496,

[57] Yoshikiyo K, Kratz K, Hirota K, Nishihara K, Takata M, Kurumizaka H, Horimoto S, Takeda S, Jiricny J. KIAA1018/FAN1 nuclease protects cells against genomic instability induced by interstrand cross-linking agents. Proceedings of the National Academy of Sciences United States of America, 2010, 107: 21553-21557,

[58] Yoshimura M, Kohzaki M, Nakamura J, Asagoshi K, Sonoda E, Hou E, Prasad R, Wilson SH, Tano K, Yasui A, et al.. Vertebrate POLQ and POLbeta cooperate in base excision repair of oxidative DNA damage. Molecular Cell, 2006, 24: 115-125,

[59] Zhang C, Han M, Zhang F, Yang X, Du J, Zhang H, Li W, Chen S. Enhancing antitumor efficacy of nucleoside analog 5-fluorodeoxyuridine on HER2-overexpressing breast cancer by affibody-engineered DNA nanoparticle. International Journal of Nanomedicine, 2020, 15: 885-900,

Funding

Japan Society for the Promotion of Science(JP19KK0210); Tokyo Metropolitan Government(Advanced Research Grant Number R3-2); Takeda Science Foundation; Yamada Science Foundation; Tokyo Metropolitan University